Carmel Shachar, JD, MPH and Dorit Rubinstein Reiss, LLB, PhD
Legal approaches to preserving social stability, maintaining trust, supporting therapeutic research opportunities, or diminishing disease severity deserve ethical scrutiny.
AMA J Ethics. 2020;22(1):E36-42. doi:
10.1001/amajethics.2020.36.
Being close enough to patients to care is as critical as remaining distant enough from a pathogen to be safe. This strategy simultaneously frustrates and supports public trust.
AMA J Ethics. 2020;22(1):E22-27. doi:
10.1001/amajethics.2020.22.
How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”?
AMA J Ethics. 2020;22(1):E43-49. doi:
10.1001/amajethics.2020.43.
Christopher W. Reynolds joins Ethics Talk to discuss his article, coauthored with Camilo Sánchez Meertens: “How Should Health Systems Help Clinicians Manage Bias Against Ex-combatants?”
This article considers 1990s and 2000s-era civil rights complaints in NYC and offers legal strategies for scaling health outcomes improvement nationwide.
AMA J Ethics. 2023;25(1):E48-54. doi:
10.1001/amajethics.2023.48.